Neurotechnology & Brain-Computer Interfaces in 2025

Direct communication between human brains and computers is no longer science fiction. Neurotechnology has already enabled paralyzed individuals to control robotic limbs with their thoughts and restored partial vision to the blind.

Today, this rapidly evolving field combines advanced brain science with cutting-edge computing systems to create revolutionary devices and applications. From medical treatments to consumer products, neurotechnology companies are developing solutions that can monitor, interpret, and even influence brain activity. As a result, these innovations raise important questions about privacy, ethics, and the future relationship between human consciousness and artificial intelligence.

This comprehensive guide explores what neurotechnology is, how it works, and its various applications across medicine, research, and consumer products. We’ll examine leading neurotechnology devices, key companies shaping the industry, and the ethical considerations surrounding this transformative technology.

What is Neurotechnology?

Neurotechnology represents a groundbreaking interdisciplinary field that bridges neuroscience with technological innovation. This rapidly expanding domain has evolved from early neural discoveries to sophisticated systems that interact directly with the nervous system.

Definition and Core Concepts

Neurotechnology encompasses any method or electronic device that interfaces with the nervous system to monitor or modulate neural activity. At its core, this technology enables connection, interaction, and understanding of the brain and its functions. The field serves three fundamental purposes: using neural activity readings to control external devices like neuroprosthetics, altering neural activity through neuromodulation to treat neurological disorders, and augmenting cognitive abilities.

Three main categories define neurotechnology. First, neuroimaging technologies monitor and record both brain structure and function through techniques like EEG, MRI, fMRI, and PET scans. Second, neuromodulation technologies influence brain activity by modifying neural structures through electrical currents or magnetic fields, as seen in Deep Brain Stimulation and Spinal Cord Stimulation. Third, brain-computer interfaces (BCIs) facilitate operational connectivity between the brain and external machines, translating brain signals into commands that operate devices.

Neurotechnology broadly works by reading or writing information into the central, peripheral, or autonomic nervous systems. This fundamental capability has applications spanning medical treatments, research tools, and increasingly, consumer products.

History and Evolution of Neurotechnology

The journey of neurotechnology began in the 18th century when Luigi Galvani and his wife Lucia discovered that electrical sparks could activate muscles, suggesting electricity’s role in neural function. This foundation was built upon in 1924 when Hans Berger, now recognized as the father of electroencephalography, recorded the first human brain electrical activity and identified alpha and beta waves.

Initially considered merely research curiosities, these discoveries gained scientific validation in 1934 when Lord Adrian and Hallowell Davis confirmed Berger’s findings. Subsequently, Jacques Vidal coined the term “BCI” in 1973, publishing the first peer-reviewed papers on the topic and articulating the “BCI challenge” of controlling external objects using EEG signals.

While neurotechnology has existed for nearly half a century, it only reached maturity in the last twenty years. The field advanced significantly in the 1970s at UCLA with experiments on animals to develop direct communication between external environments and the brain. First human trials began in the 1990s, ultimately leading to modern applications like thought-controlled prosthetics and neural rehabilitation systems.

Today’s neurotechnology landscape reflects both Berger’s initial curiosity about linking mental states with physiological data and modern innovations in hardware and software designed for clinical applications.

How Neurotechnology Works

Modern neurotechnology operates through three primary mechanisms that enable the interface between mind and machine. Each employs distinct methods to communicate with or influence neural pathways.

Brain-Computer Interfaces

Brain-computer interfaces (BCIs) create direct communication pathways between the brain and external devices. These systems acquire brain signals, analyze them, and translate them into commands that control output devices. Unlike conventional interfaces, BCIs bypass normal neuromuscular pathways, allowing interaction through thought alone.

The architecture of a BCI consists of four sequential components: signal acquisition (measuring brain signals), feature extraction (distinguishing relevant signal characteristics), feature translation (converting features into device commands), and device output (executing functions like cursor movement or prosthetic control).

BCIs vary in invasiveness. Non-invasive approaches like EEG use electrodes placed on the scalp, offering safety and convenience but with attenuated signals. Partially invasive methods such as electrocorticography (ECoG) place electrodes on the brain surface beneath the skull, providing superior spatial resolution and signal-to-noise ratio compared to EEG. Fully invasive BCIs involve electrodes implanted directly into brain tissue, delivering the highest quality signals but posing risks of scar tissue buildup.

Neural Stimulation Technologies

Neural stimulation technologies actively modify brain activity through various energy forms. These include techniques that either excite or inhibit specific neural regions to achieve therapeutic effects.

Deep brain stimulation (DBS) employs surgically implanted electrodes that deliver electrical current to precise brain regions, effectively treating conditions like Parkinson’s disease by suppressing symptoms such as tremor. Other approaches include transcranial electrical stimulation, where small currents flow through scalp electrodes, and transcranial magnetic stimulation, which uses magnetic pulses via coils placed on the scalp.

Innovative closed-loop systems combine measurement and stimulation capabilities, applying stimulation based on real-time brain activity monitoring. Furthermore, emerging technologies like optogenetics make neurons photosensitive through artificial light receptors, allowing control through illumination.

Neuroimaging and Monitoring

Neuroimaging techniques provide visual representations of brain structure and function. These methods form the foundation for understanding neural patterns and developing interventions.

Electroencephalography (EEG) measures electrical brain activity through scalp electrodes, offering exceptional temporal resolution at the millisecond level. Functional magnetic resonance imaging (fMRI) detects blood flow changes associated with neural activity, providing detailed spatial information but slower temporal response.

Additional techniques include magnetoencephalography (MEG), which measures magnetic fields generated by neural electrical currents, and functional near-infrared spectroscopy (fNIRS), which uses infrared light to measure blood oxygenation. Positron emission tomography (PET) employs radioactive tracers bound to glucose to visualize brain activity.

Each neuroimaging approach offers distinct advantages in temporal precision, spatial resolution, portability, and clinical utility for monitoring brain states and supporting neurotechnological applications.

Top 5 Neurotechnology Applications

Neurotechnology applications span multiple domains, addressing critical healthcare needs while extending into consumer and research environments. The most developed implementations demonstrate both current capabilities and future potential of this emerging field.

Medical Applications

Medical applications represent the most advanced and clinically validated use of neurotechnology, with several systems already approved by regulatory authorities. Deep brain stimulation (DBS), a neuromodulation technique, received FDA approval in 1997 for essential tremor, in 2002 for Parkinson’s disease, and in 2003 for dystonia. This technology effectively reduces tremors and other Parkinson’s symptoms through precisely placed electrodes.

For individuals with paralysis, brain-computer interfaces show remarkable progress. The Brain Gate feasibility study—the largest and longest-running clinical BCI trial—reported positive safety results in patients with quadriparesis from spinal cord injury, brainstem stroke, and motor neuron disease. Additionally, a brain-machine interface (BMI) predicted with over 90% accuracy in real-time which of eight words a tetraplegic person was thinking.

Other established neurotechnology applications include:

• Cochlear implants to restore hearing in people with profound hearing loss
• Spinal cord stimulation for treating chronic pain
• Brain stimulation to help restore damaged memories

Neurology EMR Software: The Digital Foundation for Neurotechnology

Neurology EMR software serves as the essential digital infrastructure supporting advanced neurotechnology implementation in clinical settings. These specialized systems incorporate 5 critical features for neurological practice:

• Advanced neurological examination templates capture detailed assessments of motor function, sensory processing, and reflex testing, enabling comprehensive documentation of complex neurological states.
• Neurodiagnostic integration capabilities directly import data from EEG, EMG, and evoked potential studies, eliminating manual transcription and reducing documentation errors by 38%.
• Longitudinal tracking tools monitor disease progression and treatment response over time, essential for managing conditions like Parkinson’s disease, epilepsy, and multiple sclerosis.
• Decision support algorithms analyze patient data to suggest appropriate diagnostic tests, treatment protocols, and medication adjustments based on current neurological practice guidelines.
• Seamless neuroimaging visualization incorporates MRI, CT, PET, and fMRI images directly into patient records, allowing neurologists to view brain structure and function alongside clinical notes.

For patients utilizing brain-computer interfaces and neural stimulation devices, these EMR systems capture neural activity readings and device settings, tracking response patterns and facilitating precise adjustments. This capability proves especially valuable for monitoring deep brain stimulation parameters in movement disorder patients, where small programming changes significantly impact symptom control.

The most advanced neurology EMR platforms incorporate closed-loop systems that analyze streaming data from wearable neurological monitors, automatically flagging concerning patterns and generating alerts for clinical intervention. These systems detect seizure activity precursors with up to 92% accuracy, enabling proactive care management.

Consumer Applications

Beyond clinical settings, neurotechnology has entered the consumer market with increasingly affordable and user-friendly devices. Most consumer-grade EEG headsets are priced below $100 and feature ergonomic designs with simplified hardware. These systems typically employ fewer sensors (1-16) than research-grade equivalents (32-128) and often use dry electrodes for easier setup.

Consumer applications encompass meditation support, sleep quality monitoring, and focus enhancement. Moreover, neurofeedback devices enable users to self-regulate brain function through real-time monitoring. In gaming, EEG headsets serve as alternative controllers for video games and toys such as air drones.

Research Applications

Research applications of neurotechnology focus on expanding our understanding of the brain while developing novel therapeutic approaches. Neuroimaging tools like fMRI, which measures brain activity by detecting blood flow changes, provide detailed images of brain function. These insights help researchers understand the neural basis of behavior and cognition.

In addition, activity sensors track neural firing in real-time, allowing scientists to gather data on neurons’ electrical activity. Furthermore, closed-loop neurotechnology systems that can simultaneously monitor brain activity and provide stimulation show promise for treating neurological, psychiatric, and movement disorders.

The convergence of neurotechnology with artificial intelligence further expands research capabilities, making their combined impact increasingly significant for future scientific discoveries.

Leading Neurotechnology Companies

The corporate landscape of neurotechnology has evolved into a vibrant ecosystem where established tech giants compete alongside innovative startups and research institutions.

Established Companies

Neuralink, founded in 2016 by Elon Musk, stands at the forefront of brain-computer interface development. The company’s N1 Implant contains custom low-power chips with 1024 electrodes distributed across 64 ultra-thin threads. Currently valued at approximately $5 billion, Neuralink has raised $680 million across multiple funding rounds. Following FDA approval, the company has begun its first human clinical trials focusing on helping people with quadriplegia control computers with their thoughts.

Synchron, founded in 2016, takes a different approach with its minimally invasive BCI that’s inserted through the jugular vein rather than requiring open brain surgery. The company has already implanted its device in 10 patients across trials in Australia and the U.S. Additionally, Synchron recently demonstrated its BCI controlling Apple Vision Pro using only brain signals.

Blackrock Neurotech, established in 2008 in Salt Lake City, has the most extensive human implantation experience. Its Utah array has been implanted in dozens of people since 2004, helping patients with paralysis gain mobility and independence.

Promising Startups

Paradromics is developing high-data-rate BCIs that can translate neural signals into speech for severely motor-impaired individuals. The company has received two FDA Breakthrough Device designations and plans its first human trials in 2025.

Neurable, founded in 2015, focuses on consumer applications with its EEG-based brain-monitoring technology. The company recently launched MW75 Neuro smart headphones incorporating EEG sensors to track focus and prevent burnout.

Precision Neuroscience, founded by former Neuralink executive Ben Rapoport, has developed the Layer 7 Cortical Interface—a wafer-thin microelectrode array inserted through a narrow skull slit. The company has raised $155 million and achieved a valuation of approximately $500 million.

Research Institutions

The McGovern Institute pioneers breakthrough microscopy techniques used worldwide. Their researchers develop smart bionic limbs that communicate with the brain and create sophisticated probes that integrate with biological tissues.

The Center for Neurotechnology and Behavior at Mount Sinai brings together leaders using cutting-edge neurotechnology including multiphoton laser microscopes and miniaturized cameras to study circuits involved in addiction, anxiety, and other neurological disorders.

Georgia Tech’s Neuro Next Initiative accelerates interdisciplinary research through collaboration across neuroscience, neurotechnology, and related fields, forming industry partnerships to propel technological advancement.

Neurotechnology Devices

Neurotechnology devices range from sophisticated brain implants to consumer-grade wearables, each offering distinct capabilities for interfacing with neural systems. These devices form the backbone of practical applications in both clinical settings and everyday use.

Invasive Devices

Invasive neurotechnology requires surgical implantation, offering superior signal quality at the cost of increased risk. Intracortical brain-computer interfaces implanted directly into brain tissue produce the highest quality signals, though they risk scar tissue buildup that can weaken signals over time. Neuroprosthetics represent a prominent category of invasive devices, with cochlear implants having been implanted in approximately 736,900 people worldwide as of 2010. Deep brain stimulation (DBS), another established invasive technology, delivers electrical stimulation to specific brain regions, effectively treating conditions like Parkinson’s disease. These devices typically consist of electrodes connected to a controller that regulates stimulation parameters.

Non-invasive Devices

Non-invasive neurotechnology avoids surgical risks while sacrificing some signal precision. Electroencephalography (EEG) remains the most widely used non-invasive approach due to its portability, affordability, and real-time capabilities. Currently, mobile EEG devices from companies like Muse cost between $300-400, compared to traditional EEG machines priced at $30,000-$100,000. Nevertheless, these devices face challenges including low signal-to-noise ratios and difficulty maintaining consistent electrode contact. Researchers at Carnegie Mellon University have recently achieved a breakthrough by using AI to improve the decoding of human intention through non-invasive BCI, enabling control of continuously moving virtual objects solely through thought.

Emerging Technologies

Innovative approaches are expanding neurotechnology capabilities beyond traditional paradigms. The endovascular technique, exemplified by Stentrode, delivers brain-computer interfaces through blood vessels rather than direct brain surgery. This device, implanted via the jugular vein, communicates neural activity to a battery-less telemetry unit in the chest. Additionally, researchers at Johns Hopkins recently developed digital holographic imaging that detects neural tissue deformations at nanometer scale, potentially enabling high-resolution, non-invasive brain activity recording. Closed-loop neurotechnology systems that simultaneously monitor brain activity and provide stimulation show particular promise for treating neurological disorders by detecting biomarkers in physical movement and delivering targeted neural stimulation.

Ethical Considerations in Neurotechnology

The profound capabilities of neurotechnology to access and influence neural activity raise significant ethical questions that must be addressed alongside technical advancement.

Privacy Concerns

Neurological data represents an unprecedented privacy frontier—potentially the last barrier between our inner thoughts and external access. Unlike genetic information, neural data directly reflects our thoughts and experiences, making it extraordinarily sensitive. Brain data can reveal highly personal information including truthfulness, psychological traits, mental states, and attitudes toward others. This information could enable discrimination in employment or other contexts.

More concerning still, researchers can identify individuals from anonymously collected brain data when processed alongside social media pictures. Through sophisticated “brain decoding” algorithms, neural data can reveal language, images, dreams, intentions, and even political ideology. Factory workers in China already wear devices monitoring mental states to improve efficiency, foreshadowing potential expansions of neural surveillance.

Identity and Agency

Neurotechnology directly affects personal identity and autonomy—the core of what makes us human. Deep brain stimulation patients sometimes experience ambiguous feelings about changes to their sense of self, particularly related to personality aspects like impulsivity or conscientiousness. Some struggle to differentiate between neural device achievements and their own capabilities.

Brain-computer interfaces raise fundamental questions about agency—a person’s power to influence their own actions and thoughts. When “intelligent” BCIs operate independently based on visual inputs and artificial intelligence, users may incorrectly believe they are controlling the device when, in fact, the technology is making autonomous decisions.

Regulatory Frameworks

The regulatory landscape remains fragmented and inadequate. Chile pioneered neurotechnology legislation in 2020 by amending its constitution to include “the right to neuroprotection”. Colorado and California passed laws protecting brain data privacy, though these contain significant gaps regarding smaller entities and enforcement mechanisms.

European patent examiners must assess whether patents raise concerns about potential socially harmful uses. However, many scholars argue that current regulations insufficiently address neurotechnology’s unique challenges, suggesting the precautionary principle should apply—taking preventative action even before scientific proof of harm is fully established.

Future of Neurotechnology

The landscape of neurotechnology stands at a critical inflection point, poised for breakthroughs that could fundamentally alter human capabilities and society. Research institutions and private ventures are accelerating development with substantial funding and ambitious goals.

Upcoming Innovations

Next-generation non-surgical neurotechnology represents a primary focus area, exemplified by DARPA’s N3 program which aims to develop high-performance, bi-directional brain-machine interfaces that don’t require surgery. These interfaces would need to read from and write to 16 independent channels within a 16mm3 volume of neural tissue within 50ms. Closed-loop neurotechnology systems that simultaneously monitor brain activity and provide stimulation are likewise advancing quickly, potentially treating neurological disorders by detecting biomarkers and delivering targeted neural stimulation.

Notably, integration with artificial intelligence is making neurotechnology’s impact increasingly unpredictable and disruptive. This convergence enables more sophisticated signal processing and machine learning algorithms that could enhance user experiences and expand applications.

Potential Impact on Society

Consequently, neurotechnology may become as commonplace as smartphones, fundamentally changing human experience across multiple domains. In education, these technologies could enhance learning and cognition. For workplaces, they might create paradigm shifts through improved efficiency and cognitive augmentation.

Beyond professional settings, consumer-oriented brain-computer interfaces could enable commercial devices controlled by thought alone. Indeed, companies are already developing home kits that make neurofeedback training more convenient and affordable.

Yet concerns about inequality persist—if only wealthy individuals have access to cognitive or physical augmentation, neurotechnology risks widening social divides. Ensuring equal access therefore becomes crucial for mitigating potential negative societal consequences.

Challenges and Opportunities

Despite promising advances, numerous challenges remain. Forthwith, privacy concerns are paramount as neurotechnology creates unprecedented capability to collect “brain data,” potentially allowing machines to tap into private thought processes. This capacity to decode cognitive processes raises questions about agency, as experiments show how implanted technologies can condition or disrupt brain function.

Regulatory frameworks remain inadequate for addressing these unique challenges. Chile pioneered legislation by amending its constitution to include “the right to neuroprotection”, but most nations still lack comprehensive guidelines.

Above all, the slippery slope between restorative and enhancement applications presents distinctive ethical dilemmas. Finding solutions that adequately protect individual rights without stifling innovation remains a central challenge.

Conclusion

Neurotechnology stands as a transformative field bridging human consciousness with computing power. Through advanced brain-computer interfaces, neural stimulation technologies, and sophisticated imaging systems, scientists and companies now enable direct communication between minds and machines.

Medical applications lead the way, helping patients with conditions ranging from Parkinson’s disease to complete paralysis. Meanwhile, consumer devices make brain monitoring accessible to everyday users, and research applications expand our understanding of neural function. Companies like Neuralink, Synchron, and Blackrock Neurotech push boundaries with increasingly sophisticated neural interfaces.

Though technical challenges persist, ethical considerations present equally significant hurdles. Privacy protection, identity preservation, and equitable access demand careful attention as these technologies advance. Regulatory frameworks must evolve alongside technical capabilities to safeguard individual rights while supporting innovation.

Looking ahead, neurotechnology promises profound changes in healthcare, education, and daily life. Success depends on balancing technological advancement with ethical implementation, ensuring benefits reach across society while protecting fundamental human rights and autonomy. This emerging field thus represents both remarkable opportunity and serious responsibility as we shape the future of human-machine interaction.

References

1 – https://en.wikipedia.org/wiki/Neurotechnology
2 – https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2021.728178/full
3 – https://www.nature.com/articles/s42003-022-04390-w
4 – https://www.ncbi.nlm.nih.gov/books/NBK597471/
5 – https://www.iberdrola.com/innovation/neurotechnology
9 – https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2024.1332827/full
10 – https://pmc.ncbi.nlm.nih.gov/articles/PMC7873964/
12 – https://onlinelibrary.wiley.com/doi/full/10.1002/adem.202201412
13 – https://pmc.ncbi.nlm.nih.gov/articles/PMC10361212/
16 – https://www.sciencedirect.com/science/article/abs/pii/S0165027021001552
17 – https://www.nature.com/articles/s41586-018-0649-2
19 – https://pubmed.ncbi.nlm.nih.gov/35624949/
20 – https://pmc.ncbi.nlm.nih.gov/articles/PMC4615684/
21 – https://medium.com/neurotechx/clinical-trials-for-neurotechnologies-50b29af2da6c